← FDA Drug Approvals (Drugs@FDA)
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2026-03-31
Drug application
- FDA Application #
ANDA208465- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
- Generic name
- Hydrochlorothiazide
- Active ingredients
- HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SCIEGEN PHARMS
- First approval
- 2026-03-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown